And Here We Go Again! NASDAQ Article: Forget Cannabis: Psychedelic Medicine Is the Better Investing Opportunity
Cannabis Law Report
MARCH 2, 2020
The global march toward cannabis legalization has seemingly awoken another long dormant area of scientific interest: psychedelics as medicine. Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to Compass Pathways ‘ psilocybin therapy for treatment-resistant depression.
Let's personalize your content